Close

Pacira Pharmaceuticals (PCRX) PT Lifted to $133 at Wedbush

February 25, 2015 6:57 AM EST Send to a Friend
Wedbush analyst Liana Moussatos reiterated an Outperform rating and boosted her price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $133.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login